Table 4.
All patients | DCMR-pos | DCMR-neg | ||
---|---|---|---|---|
n = 1532 | n = 609 | n = 923 | p† | |
Hemodynamic data | ||||
Dobutamine dose (μg/kg/min) | 35 ± 8 | 35 ± 8 | 35 ± 8 | 0.5 |
Atropine dose (mg) | 0.25 ± 0.35 | 0.26 ± 0.36 | 0.24 ± 0.35 | 0.27 |
Resting HR, beats/minute | 73 ± 13 | 72 ± 14 | 73 ± 13 | 0.008 |
Peak HR, beats/minute | 139 ± 10 | 138 ± 11 | 140 ± 10 | <0.001 |
Target HR achieved, % | 94 | 91 | 97 | <0.001 |
Resting SBP, mmHg | 132 ± 22 | 133 ± 23 | 132 ± 22 | 0.68 |
Peak SBP, mmHg | 141 ± 30 | 141 ± 32 | 141 ± 29 | 0.83 |
Resting Rate Pressure Product | 9691 ± 2748 | 9607 ± 2829 | 9747 ± 2695 | 0.12 |
Peak Rate Pressure Product | 18759 ± 4275 | 18893 ± 4351 | 18667 ± 4236 | 0.31 |
Values are expressed as mean ± SD or %, †DCMR-pos vs. DCMR-neg patients